Print this page

Consolidated Statement of Changes in Net Equity 

XLS

 

 

 

 

 

 

 

 

 

 

 

 

 

Equity capital

 

Retained earnings

Gains/losses recognized in equity

 

 

 

€ million

General partner’s equity Merck KGaA

Sub­scribed capital Merck KGaA

Capital reserves (share premium) Merck KGaA

Retained earnings/Net retained profit

Re­measure­ment of defined benefit plans

Avail­able-for-sale financial assets

Deri­vative financial instru­ments

Currency translation difference

Equity attributable to Merck KGaA share­holders

Non-controlling interests

Total equity

1

Previous year’s figures have been adjusted.

Balance as of January 1, 2013

397.2

168.0

3,813.7

5,383.9

–645.3

1.2

–29.5

1,272.2

10,361.4

53.4

10,414.8

Profit after tax

–

–

–

582.0

–

–

–

–

582.0

3.1

585.1

Other comprehensive income

–

–

–

–

–36.8

0.3

31.6

–82.1

–87.0

–2.9

–89.9

Comprehensive income

–

–

–

582.0

–36.8

0.3

31.6

–82.1

495.0

0.2

495.2

Dividend payments

–

–

–

–109.9

–

–

–

–

–109.9

–3.0

–112.9

Transactions with no change of control

–

–

–

2.1

–

–

–

–

2.1

–2.1

–

Changes in scope of consolidation/Other

–

–

–

–1.0

–

–

–

–

–1.0

0.9

–0.1

Balance as of June 30, 20131

397.2

168.0

3,813.7

5,857.0

–682.1

1.5

2.1

1,190.1

10,747.5

49.5

10,797.0

 

 

 

 

 

 

 

 

 

 

 

 

Balance as of January 1, 2014

397.2

168.0

3,813.7

6,090.1

–562.7

1.0

44.2

1,068.5

11,020.0

49.2

11,069.2

Profit after tax

–

–

–

628.5

–

–

–

–

628.5

4.9

633.4

Other comprehensive income

–

–

–

–

–200.1

0.5

–59.7

87.0

–172.3

2.0

–170.3

Comprehensive income

–

–

–

628.5

–200.1

0.5

–59.7

87.0

456.2

6.9

463.1

Dividend payments

–

–

–

–122.8

–

–

–

–

–122.8

–2.7

–125.5

Transactions with no change of control

–

–

–

–192.9

–

–

–

–

–192.9

–155.4

–348.3

Changes in scope of consolidation/Other

–

–

–

–

–

–

–

–

–

156.4

156.4

Balance as of June 30, 2014

397.2

168.0

3,813.7

6,402.9

–762.8

1.5

–15.5

1,155.5

11,160.5

54.4

11,214.9
© Merck KGaA, Darmstadt, Germany, Last Update 2013/08/06